" Alzheimer’s disease may result from prolonged exposure to a specific neurotransmitter that is released when the brain is injured or diseased. "
Why current Alzheimer’s disease treatments might be ineffective

New research out of Penn State University, reported in Dementia News, suggests that current approaches to develop treatments for Alzheimer’s disease that selectively target amyloid beta have so far proven ineffective in human clinical trials because they may be failing to target the flow-on effects that occur in the brain after amyloid beta plaques appear.

This research was published in the Journal Nature Communications and supports the notion that amyloid beta plaques likely cause the initial damage, but the eventual neurodegeneration seen in Alzheimer’s disease may result from prolonged exposure to a specific neurotransmitter that is released when the brain is injured or diseased.

To find out more visit Dementia News.

 Posted: June 23rd, 2014
Discussion

No discussion yet.

Add a comment:

Call the National Dementia Helpline: 1800 100 500